Statement Of Comprehensive Income [Abstract]

ABIONYX Pharma - Filing #2810725

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	0 EUR	3 518 EUR	0 EUR	0 EUR	3 518 EUR	0 EUR	0 EUR	0 EUR	0 EUR	0 EUR	4 206 EUR	0 EUR	4 206 EUR	0 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	0 EUR	34,000 EUR	0 EUR	34,000 EUR	0 EUR	0 EUR	0 EUR	0 EUR	0 EUR	182,000 EUR	182,000 EUR	0 EUR	0 EUR	0 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	0 EUR	23,000 EUR	0 EUR	0 EUR	0 EUR	0 EUR	23,000 EUR	0 EUR	0 EUR	0 EUR	39,000 EUR	0 EUR	0 EUR	39,000 EUR
Comprehensive income	—	3 575 EUR	—	—	—	—	—	—	—	—	3 985 EUR	—	—	—